SHPH Annual EBITDA
-$4.09 M
-$2.04 M-99.50%
31 December 2023
Summary:
As of January 23, 2025, SHPH annual earnings before interest, taxes, depreciation & amortization is -$4.09 million, with the most recent change of -$2.04 million (-99.50%) on December 31, 2023. During the last 3 years, it has fallen by -$3.38 million (-475.77%). SHPH annual EBITDA is now -475.77% below its all-time high of -$711.20 thousand, reached on December 1, 2020.SHPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SHPH Quarterly EBITDA
-$3.51 M
-$1.91 M-119.47%
30 September 2024
Summary:
As of January 23, 2025, SHPH quarterly earnings before interest, taxes, depreciation & amortization is -$3.51 million, with the most recent change of -$1.91 million (-119.47%) on September 30, 2024. Over the past year, it has dropped by -$2.34 million (-200.72%). SHPH quarterly EBITDA is now -3424.70% below its all-time high of -$99.60 thousand, reached on March 1, 2021.SHPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SHPH TTM EBITDA
-$7.45 M
-$2.34 M-45.90%
30 September 2024
Summary:
As of January 23, 2025, SHPH TTM earnings before interest, taxes, depreciation & amortization is -$7.45 million, with the most recent change of -$2.34 million (-45.90%) on September 30, 2024. Over the past year, it has dropped by -$1.26 million (-20.43%). SHPH TTM EBITDA is now -7378.21% below its all-time high of -$99.60 thousand, reached on March 1, 2021.SHPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SHPH EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.5% | -200.7% | -20.4% |
| 3 y3 years | -475.8% | -1737.0% | -1108.2% |
| 5 y5 years | -475.8% | -1737.0% | -1108.2% |
SHPH EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -293.6% | at low | -848.8% | at low | -615.8% | at low |
| 5 y | 5-year | -475.8% | at low | -3424.7% | at low | -7378.2% | at low |
| alltime | all time | -475.8% | at low | -3424.7% | at low | -7378.2% | at low |
Shuttle Pharmaceuticals Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.51 M(+119.5%) | -$7.45 M(+45.9%) |
| June 2024 | - | -$1.60 M(+29.9%) | -$5.11 M(+3.0%) |
| Mar 2024 | - | -$1.23 M(+11.3%) | -$4.96 M(+21.0%) |
| Dec 2023 | -$4.09 M(+99.5%) | -$1.11 M(-5.2%) | -$4.09 M(-33.8%) |
| Sept 2023 | - | -$1.17 M(-19.5%) | -$6.18 M(+14.6%) |
| June 2023 | - | -$1.45 M(+292.2%) | -$5.40 M(+23.9%) |
| Mar 2023 | - | -$370.00 K(-88.4%) | -$4.36 M(-3.4%) |
| Dec 2022 | -$2.05 M | -$3.20 M(+744.6%) | -$4.51 M(+159.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$378.40 K(-7.8%) | -$1.74 M(+12.1%) |
| June 2022 | - | -$410.60 K(-21.7%) | -$1.55 M(+5.8%) |
| Mar 2022 | - | -$524.30 K(+23.7%) | -$1.47 M(+40.8%) |
| Dec 2021 | -$1.04 M(+46.3%) | - | - |
| Dec 2021 | - | -$424.00 K(+121.9%) | -$1.04 M(+68.8%) |
| Sept 2021 | - | -$191.10 K(-41.3%) | -$616.50 K(+44.9%) |
| June 2021 | - | -$325.80 K(+227.1%) | -$425.40 K(+327.1%) |
| Mar 2021 | - | -$99.60 K | -$99.60 K |
| Dec 2020 | -$711.20 K | - | - |
FAQ
- What is Shuttle Pharmaceuticals Holdings annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Shuttle Pharmaceuticals Holdings?
- What is Shuttle Pharmaceuticals Holdings annual EBITDA year-on-year change?
- What is Shuttle Pharmaceuticals Holdings quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Shuttle Pharmaceuticals Holdings?
- What is Shuttle Pharmaceuticals Holdings quarterly EBITDA year-on-year change?
- What is Shuttle Pharmaceuticals Holdings TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Shuttle Pharmaceuticals Holdings?
- What is Shuttle Pharmaceuticals Holdings TTM EBITDA year-on-year change?
What is Shuttle Pharmaceuticals Holdings annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SHPH is -$4.09 M
What is the all time high annual EBITDA for Shuttle Pharmaceuticals Holdings?
Shuttle Pharmaceuticals Holdings all-time high annual earnings before interest, taxes, depreciation & amortization is -$711.20 K
What is Shuttle Pharmaceuticals Holdings annual EBITDA year-on-year change?
Over the past year, SHPH annual earnings before interest, taxes, depreciation & amortization has changed by -$2.04 M (-99.50%)
What is Shuttle Pharmaceuticals Holdings quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SHPH is -$3.51 M
What is the all time high quarterly EBITDA for Shuttle Pharmaceuticals Holdings?
Shuttle Pharmaceuticals Holdings all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$99.60 K
What is Shuttle Pharmaceuticals Holdings quarterly EBITDA year-on-year change?
Over the past year, SHPH quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.34 M (-200.72%)
What is Shuttle Pharmaceuticals Holdings TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SHPH is -$7.45 M
What is the all time high TTM EBITDA for Shuttle Pharmaceuticals Holdings?
Shuttle Pharmaceuticals Holdings all-time high TTM earnings before interest, taxes, depreciation & amortization is -$99.60 K
What is Shuttle Pharmaceuticals Holdings TTM EBITDA year-on-year change?
Over the past year, SHPH TTM earnings before interest, taxes, depreciation & amortization has changed by -$1.26 M (-20.43%)